Terms: = Ovarian cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679
165 results:
1. A Relative Bioavailability, Bioequivalence, and Food Effect Study of Niraparib Tablets in Patients with Advanced Solid Tumors.
Falchook G; Patnaik A; Richardson DL; Harvey RD; Sharma MR; Hafez N; Hamilton E; Piha-Paul SA; Barve M; Wise-Draper T; Patel MR; Dowlati A; Pascuzzo J; Tang SC; Faltermeier C; Malinowska IA; Shtessel L; Striha A; Potocka E
Clin Ther; 2024 Mar; 46(3):228-238. PubMed ID: 38423866
[TBL] [Abstract] [Full Text] [Related]
2. Air quality and cancer risk in the All of Us Research Program.
Craver A; Luo J; Kibriya MG; Randorf N; Bahl K; Connellan E; Powell J; Zakin P; Jones RR; Argos M; Ho J; Kim K; Daviglus ML; Greenland P; Ahsan H; Aschebrook-Kilfoy B
Cancer Causes Control; 2024 May; 35(5):749-760. PubMed ID: 38145439
[TBL] [Abstract] [Full Text] [Related]
3. CXCR4-directed PET/CT with [
Dreher N; Hahner S; Fuß CT; Schlötelburg W; Hartrampf PE; Serfling SE; Schirbel A; Samnick S; Higuchi T; Weich A; Lapa C; Rosenwald A; Buck AK; Kircher S; Werner RA
Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1383-1394. PubMed ID: 38082196
[TBL] [Abstract] [Full Text] [Related]
4. NMR-identification of the interaction between BRCA1 and the intrinsically disordered monomer of the Myc-associated factor X.
Epasto LM; Pötzl C; Peterlik H; Khalil M; Saint-Pierre C; Gasparutto D; Sicoli G; Kurzbach D
Protein Sci; 2024 Jan; 33(1):e4849. PubMed ID: 38037490
[TBL] [Abstract] [Full Text] [Related]
5. Fertility preservation in patients with gynaecologic malignancy: Response to ovarian stimulation and long-term outcomes.
Tsonis O; Kopeika J
Eur J Obstet Gynecol Reprod Biol; 2023 Nov; 290():93-100. PubMed ID: 37757729
[TBL] [Abstract] [Full Text] [Related]
6. Benefits of Soybean in the Era of Precision Medicine: A Review of Clinical Evidence.
Kang JH; Dong Z; Shin SH
J Microbiol Biotechnol; 2023 Dec; 33(12):1552-1562. PubMed ID: 37674385
[TBL] [Abstract] [Full Text] [Related]
7. Preclinical studies of a PARP targeted, Meitner-Auger emitting, theranostic radiopharmaceutical for metastatic ovarian cancer.
Hoffman SLV; Mixdorf JC; Kwon O; Johnson TR; Makvandi M; Lee H; Aluicio-Sarduy E; Barnhart TE; Jeffery JJ; Patankar MS; Engle JW; Bednarz BP; Ellison PA
Nucl Med Biol; 2023; 122-123():108368. PubMed ID: 37490805
[TBL] [Abstract] [Full Text] [Related]
8. A comparative study of [
Xi Y; Sun L; Che X; Huang X; Liu H; Wang Q; Meng H; Miao Y; Qu Q; Hai W; Li B; Feng W
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2885-2898. PubMed ID: 37093313
[TBL] [Abstract] [Full Text] [Related]
9. Circulating Tumor Cell Detection by Liquid Biopsy during Early-Stage Endometrial cancer Surgery: A Pilot Study.
Francini S; Duraes M; Rathat G; Macioce V; Mollevi C; Pages L; Ferrer C; Cayrefourcq L; Alix-Panabières C
Biomolecules; 2023 Feb; 13(3):. PubMed ID: 36979364
[TBL] [Abstract] [Full Text] [Related]
10. Systemic exposure to cisplatin and paclitaxel after intraperitoneal chemotherapy in ovarian cancer.
de Jong LAW; Lambert M; van Erp NP; de Vries L; Chatelut E; Ottevanger PB
Cancer Chemother Pharmacol; 2023 Mar; 91(3):247-256. PubMed ID: 36892677
[TBL] [Abstract] [Full Text] [Related]
11. Initial Experience with the Radiotracer 18F-Fluciclovine PET/CT in ovarian cancer.
Buehner TM; Liotta M; Potkul RK; Wagner RH; Savir-Baruch B
Mol Imaging Biol; 2024 Feb; 26(1):45-52. PubMed ID: 36754935
[TBL] [Abstract] [Full Text] [Related]
12. Discovery of Highly Potent Nicotinamide Phosphoribosyltransferase Degraders for Efficient Treatment of ovarian cancer.
Bi K; Cheng J; He S; Fang Y; Huang M; Sheng C; Dong G
J Med Chem; 2023 Jan; 66(1):1048-1062. PubMed ID: 36563407
[TBL] [Abstract] [Full Text] [Related]
13. 68 Ga-Prostate-Specific Membrane Antigen PET/CT in ovarian Tumors : Potential to Differentiate Benign and Malignant Tumors Before Surgery: A Preliminary Report.
Kunikowska J; Bizoń M; Pełka K; Derlatka P; Olszewski M; Królicki L
Clin Nucl Med; 2023 Feb; 48(2):e60-e66. PubMed ID: 36512649
[TBL] [Abstract] [Full Text] [Related]
14. Risk of thrombosis in women with cancer undergoing controlled ovarian hyperstimulation for fertility preservation.
Melo VD; Liseth OY; Schmidt WM; Pruthi RK; Marshall AL; Shenoy CC
J Assist Reprod Genet; 2022 Dec; 39(12):2847-2856. PubMed ID: 36427171
[TBL] [Abstract] [Full Text] [Related]
15. Comparing Characteristics of Pelvic High-grade Serous Carcinomas with and without Breast cancer Gene Variants on MR Imaging.
Saida T; Shikama A; Mori K; Ishiguro T; Minaguchi T; Satoh T; Nakajima T
Magn Reson Med Sci; 2024 Jan; 23(1):18-26. PubMed ID: 36372398
[TBL] [Abstract] [Full Text] [Related]
16. Spatial-Temporal Trends in ovarian cancer Outcomes in California.
Villanueva C; Chang J; Ziogas A; Bristow RE; Vieira VM
JNCI Cancer Spectr; 2022 Nov; 6(6):. PubMed ID: 36238987
[TBL] [Abstract] [Full Text] [Related]
17. Comparative Analyses of Poly(ADP-Ribose) Polymerase Inhibitors.
Guha M; Sobol Z; Martin M; Hemkens M; Sung T; Rubitski E; Spellman R; Finkelstein M; Khan N; Hu W
Int J Toxicol; 2022 Dec; 41(6):442-454. PubMed ID: 35989659
[TBL] [Abstract] [Full Text] [Related]
18. [18F]FDG PET/CT and CA-125 in the evaluation of ovarian cancer relapse or persistence: is there any correlation?
Dondi F; Albano D; Bertagna F; Giubbini R
Nucl Med Rev Cent East Eur; 2022; 25(2):78-84. PubMed ID: 35848529
[TBL] [Abstract] [Full Text] [Related]
19. Bioequivalence of a hybrid pegylated liposomal doxorubicin hydrochloride injection and Caelyx®: A single-dose, randomized, multicenter, open-label, two-period crossover study in patients with advanced ovarian cancer.
S PS; Nagarkar RV; Puligundla KC; N LK; Boya RR; Patel AB; Goyal L; Thoke A; Patel JG; Mehta AO; Patel GN; Khan MA; Ahmad I
Eur J Pharm Sci; 2022 Sep; 176():106248. PubMed ID: 35777616
[TBL] [Abstract] [Full Text] [Related]
20. Histogram Analysis of Apparent Diffusion Coefficient on Diffusion Weighted Magnetic Resonance Imaging in Differentiation between Low and High Grade Serous ovarian cancer.
Liu X; Wang T; Wang Y; Wang J; Jin J; Zhang G; Zhang H
Curr Med Imaging; 2023; 19(2):167-174. PubMed ID: 35585829
[TBL] [Abstract] [Full Text] [Related]
[Next]
